CYCLOSPORINE-A CORRECTS DAUNORUBICIN RESISTANCE IN EHRLICH ASCITES-CARCINOMA

[11] REID M, 1983, TRANSPL P, V15, P2434

[12] ROGERS KE, 1983, CANCER RES, V43, P2741

[13] SIKIC BI, 1985, P AM ASS CANCER RES, V26, pA1346

[14] CHEMOSENSITIZERS COUNTERACTING ACQUIRED-RESISTANCE TO ANTHRACYCLINES AND VINCA ALKALOIDS INVIVO - A NEW TREATMENT PRINCIPLE [J]. CANCER TREATMENT REVIEWS, 1984, 11 : 63 - 72

[15] VERAPAMIL RESTORATION OF DAUNORUBICIN RESPONSIVENESS IN DAUNORUBICIN-RESISTANT EHRLICH ASCITES-CARCINOMA [J]. JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (05) : 1131 - 1134

[16] SLATER LM, 1986, J CLIN INVEST

[17] THE ANTICANCER AGENT ADRIAMYCIN CAN BE ACTIVELY CYTO-TOXIC WITHOUT ENTERING CELLS [J]. SCIENCE, 1982, 217 (4556) : 248 - 250

[18] TSURUO T, 1982, CANCER RES, V42, P4730

[19] TSURUO T, 1981, CANCER RES, V41, P1967

[11] REID M, 1983, TRANSPL P, V15, P2434

[12] ROGERS KE, 1983, CANCER RES, V43, P2741

[13] SIKIC BI, 1985, P AM ASS CANCER RES, V26, pA1346

[14] CHEMOSENSITIZERS COUNTERACTING ACQUIRED-RESISTANCE TO ANTHRACYCLINES AND VINCA ALKALOIDS INVIVO - A NEW TREATMENT PRINCIPLE [J]. CANCER TREATMENT REVIEWS, 1984, 11 : 63 - 72

[15] VERAPAMIL RESTORATION OF DAUNORUBICIN RESPONSIVENESS IN DAUNORUBICIN-RESISTANT EHRLICH ASCITES-CARCINOMA [J]. JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (05) : 1131 - 1134

[16] SLATER LM, 1986, J CLIN INVEST

[17] THE ANTICANCER AGENT ADRIAMYCIN CAN BE ACTIVELY CYTO-TOXIC WITHOUT ENTERING CELLS [J]. SCIENCE, 1982, 217 (4556) : 248 - 250

[18] TSURUO T, 1982, CANCER RES, V42, P4730

[19] TSURUO T, 1981, CANCER RES, V41, P1967